Q2 2024 Holdings
Filed 2024-08-07 | 8 holdings | $77.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $26.9M | 498,558 | 34.8% |
| Contineum Therapeutics, Inc.(CTNM) | Common Stock | 21217B100 | $16.2M | 918,163 | 20.9% |
| Skye Bioscience, Inc.(SKYE) | Common Stock | 83086J200 | $16.1M | 2,007,704 | 20.8% |
| Repare Therapeutics, Inc.(RPTX) | Common Stock | 760273102 | $8.7M | 2,646,657 | 11.3% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $3.5M | 506,821 | 4.5% |
| Passage Bio, Inc. | Common Stock | 702712100 | $3.2M | 4,026,417 | 4.1% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $2.2M | 3,561,150 | 2.8% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $510.3K | 1,457,937 | 0.7% |